108 related articles for article (PubMed ID: 15736456)
1. Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma.
Iizuka N; Oka M; Tamesa T; Hamamoto Y; Yamada-Okabe H
Anticancer Res; 2004; 24(6):4085-9. PubMed ID: 15736456
[TBL] [Abstract][Full Text] [Related]
2. In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma.
Sohda T; Iwata K; Soejima H; Kamimura S; Shijo H; Yun K
J Hum Genet; 1998; 43(1):49-53. PubMed ID: 9609998
[TBL] [Abstract][Full Text] [Related]
3. [VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell].
Ge YJ; Xie XY; Yang B; Chai XJ; Zhang YC; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):770-4. PubMed ID: 19950580
[TBL] [Abstract][Full Text] [Related]
4. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
5. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
Li H; Zhang N
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
[TBL] [Abstract][Full Text] [Related]
6. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P
Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma.
Wu J; Qin Y; Li B; He WZ; Sun ZL
Genomics; 2008 May; 91(5):443-50. PubMed ID: 18358696
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.
d'Arville CN; Nouri-Aria KT; Johnson P; Williams R
Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351
[TBL] [Abstract][Full Text] [Related]
9. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
Manoharan H; Babcock K; Pitot HC
Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
[TBL] [Abstract][Full Text] [Related]
10. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level.
Sohda T; Yun K; Iwata K; Soejima H; Okumura M
Lab Invest; 1996 Sep; 75(3):307-11. PubMed ID: 8804354
[TBL] [Abstract][Full Text] [Related]
12. [The significance and promoter expression of insulin-like growth factor-II gene in human hepatocellular carcinoma].
Tang SH; Yang DH; Huang W; Zhou M; Zhou HK; Lu XH; Ye G
Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):456-8. PubMed ID: 16792873
[No Abstract] [Full Text] [Related]
13. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
14. [The imprinting status and expression of insulin-like growth factor 2 gene in human hepatocellular carcinoma].
He WZ; Qin Y; Li B; Liu JY; Sun ZL; Sun ZF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):466-9. PubMed ID: 15291100
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P
Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387
[TBL] [Abstract][Full Text] [Related]
16. Biallelic expression of the H19 gene during spontaneous hepatocarcinogenesis in the albumin SV40 T antigen transgenic rat.
Manoharan H; Babcock K; Willi J; Pitot HC
Mol Carcinog; 2003 Sep; 38(1):40-7. PubMed ID: 12949842
[TBL] [Abstract][Full Text] [Related]
17. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
[TBL] [Abstract][Full Text] [Related]
18. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.
Vernucci M; Cerrato F; Besnard N; Casola S; Pedone PV; Bruni CB; Riccio A
Oncogene; 2000 Dec; 19(54):6376-85. PubMed ID: 11175353
[TBL] [Abstract][Full Text] [Related]
19. [Early diagnostic value of abnormal expression of insulin-like growth factor (IGF)-II and IGF-II-mRNA in hepatocellular carcinoma patients].
Dong ZZ; Yao DF; Wu XH; Shi GS; Qiu LW; Wu W; Su XQ
Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):866-8. PubMed ID: 16313745
[No Abstract] [Full Text] [Related]
20. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
